Trial Profile
Comparison of three batches of the Japanese encephalitis vaccine IC51. Double blind, randomized, controlled phase 3 study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Aug 2020
Price :
$35
*
At a glance
- Drugs IC 51 (Primary)
- Indications Japanese encephalitis
- Focus Pharmacodynamics; Registrational
- Sponsors Intercell; Valneva
- 30 Jan 2008 New trial record.